This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Yong-Sam Jung: Innovator in Ischemic Disease Treatment
Introduction
Yong-Sam Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating ischemic diseases. His innovative work has the potential to impact the lives of many suffering from these conditions.
Latest Patents
Yong-Sam Jung holds a patent for "Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same." This patent describes aminopyrazole derivatives that can significantly reduce ischemic cell death. The compounds developed can be effectively utilized for the prevention and treatment of ischemic diseases, offering protection to vital organs.
Career Highlights
Jung is affiliated with the Korea Research Institute of Chemical Technology, where he conducts his research and development activities. His work focuses on creating innovative solutions to complex medical challenges, particularly those related to ischemic conditions.
Collaborations
Some of his notable coworkers include Eunhee Kim and Nakjeong Kim, who contribute to the collaborative efforts in research and development at the institute.
Conclusion
Yong-Sam Jung's contributions to the field of medicinal chemistry, particularly through his patent on aminopyrazole derivatives, highlight his role as an innovator in the treatment of ischemic diseases. His work continues to pave the way for advancements in medical therapies.